Breast cancer prognosis and treatment mostly relies on a few markers such as the estrogen receptor (ER), progesterone receptor (PgR), the human epidermal growth factor receptor 2 (HER2/neu) and tumor stage. Here, ESR1 is linked to neoplasm.